Incorrect low glucose readings over an extended period of time could lead to improper treatment decisions for people living with diabetes, the company said.
‘A company can report outstanding results and still trade at a price that requires perfect performance for many years,’ fund manager Tim Schwarzenberger said.
Incorrect low glucose readings over an extended period of time could lead to improper treatment decisions for people living with diabetes, the company said.
‘A company can report outstanding results and still trade at a price that requires perfect performance for many years,’ fund manager Tim Schwarzenberger said.